Windtree Therapeutics has signed a $520 million new financing agreement, which will be used to purchase BNB.
By: theblockbeats.news|2025/07/25 03:22:18
BlockBeats News, July 25th, Nasdaq-listed biotechnology company Windtree Therapeutics (WINT) announced that it has entered into a share purchase agreement of up to $500 million to establish an Equity Line of Credit (ELOC). Additionally, the company has also signed an additional $20 million stock purchase agreement with Build and Build Corp.
The total funding size of this round reaches up to $520 million, with 99% of the funds to be used to purchase BNB. The company plans to officially start using the funds after obtaining shareholder approval to increase the number of authorized common shares.
Ripple e SEC chegam em um acordo, encerrando o processo judicial
WEEX rouba a cena no BlockchainRIO 2025
Você também pode gostar
Compartilhar
Ganhadores
Últimas notícias sobre cripto
02:58
A co-fundadora Lopes Lara se torna a bilionária mais jovem do mundo.
02:56
Cryptocurrency Fear and Greed Índice Rebounds to 28, Exiting "Extreme Fear" Range
02:53
Os rendimentos da JGB aumentam como o mercado se concentra nos dados econômicos desta semana
02:51
NewGen: Em 28 de novembro, já comprou 13,000.23 SOL
02:27
Prominent Analyst: Pode Ethereum quebrar $3,700 para validar se o mercado de touros terminou
Leia mais
Comunidade
Atendimento ao cliente:@weikecs
Parcerias comerciais:@weikecs
Quant trading e MM:[email protected]
Serviços VIP:[email protected]